Quantcast
Home > Quotes > BCYC

Bicycle Therapeutics plc American Depositary Shares (BCYC) Quote & Summary Data

BCYC 
$10.74
*  
0.63
5.54%
Get BCYC Alerts
*Delayed - data as of Jun. 25, 2019 15:44 ET  -  Find a broker to begin trading BCYC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BCYC Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 10.74 / $ 10.81
1 Year Target
22
Today's High / Low
$ 11.6999 / $ 10.50
Share Volume
26,402
50 Day Avg. Daily Volume
N/A
Previous Close
$ 11.37
52 Week High / Low
$ 14.91 / $ 10.60
Market Cap
190,059,519
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
26,402
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $10.74 is 1.32% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 11.6999 $ 14.91
 Low: $ 10.50 $ 10.60

Company Description (as filed with the SEC)

We are a clinical-stage biopharmaceutical company developing a novel class of medicines, which we refer to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained to form two loops which stabilize their structural geometry. This constraint is designed to confer high affinity and selectivity and the relatively large surface area presented by the molecule allows targets to be drugged that have historically been intractable to non-biological approaches. Bicycles are a unique therapeutic modality combining the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic, or PK, properties of a small molecule. Bicycles are excreted by the kidney rather than the liver and have shown no signs of immunogenicity to date, which we believe together support a favorable toxicological profile.  ... More ...  



Risk Grade

Where does BCYC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 11.30
Open Date:
Jun. 25, 2019
Close Price:
$ 11.37
Close Date:
Jun. 24, 2019


Consensus Recommendation

Analyst Info